BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 233 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $920,400 | +102.1% | 130,000 | +100.9% | 0.00% | +33.3% |
| Q2 2023 | $455,488 | -35.7% | 64,700 | -23.9% | 0.00% | 0.0% |
| Q1 2023 | $708,900 | +147.0% | 85,000 | +240.0% | 0.00% | 0.0% |
| Q4 2022 | $287,000 | -74.8% | 25,000 | -82.1% | 0.00% | -80.0% |
| Q1 2019 | $1,140,000 | +8.7% | 140,000 | +7.7% | 0.02% | +7.1% |
| Q4 2018 | $1,049,000 | -37.5% | 130,000 | -40.9% | 0.01% | -33.3% |
| Q3 2018 | $1,679,000 | -2.3% | 220,000 | -26.7% | 0.02% | -12.5% |
| Q2 2018 | $1,719,000 | -35.6% | 300,000 | -46.4% | 0.02% | -56.4% |
| Q1 2018 | $2,671,000 | – | 560,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |